A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Muscle-Invasive Bladder Cancer Patients after Partial Cystectomy. (1st March 2022)
- Record Type:
- Journal Article
- Title:
- A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Muscle-Invasive Bladder Cancer Patients after Partial Cystectomy. (1st March 2022)
- Main Title:
- A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Muscle-Invasive Bladder Cancer Patients after Partial Cystectomy
- Authors:
- Zhan, Xiangpeng
Chen, Tao
Jiang, Ming
Deng, Wen
Liu, Xiaoqiang
Chen, Luyao
Fu, Bin - Other Names:
- Raza Faisal Academic Editor.
- Abstract:
- Abstract : Purpose . To establish a prognostic model that estimates cancer-specific survival (CSS) probability for muscle-invasive bladder cancer patients undergoing partial cystectomy. Patients and Methods . 866 patients from the Surveillance, Epidemiology, and End Results (SEER) database (2004–2015) were enrolled in our study. These patients were randomly divided into the development cohort ( n = 608) and validation cohort ( n = 258) at a ratio of 7 : 3. A Cox regression was performed to select the predictors associated with CSS. The Kaplan–Meier method was used to analyze the survival outcome between different risk groups. The calibration curves, receiver operating characteristic (ROC) curves, and the concordance index (C-index) were utilized to evaluate the performance of the model. Results . The nomogram incorporated age, histology, T stage, N stage, M stage, regional nodes examined, and tumour size. The C-index of the model was 0.733 (0.696–0.77) in the development cohort, while this value was 0.707 (0.705–0.709) in the validation cohort. The AUC of the nomogram was 0.802 for 1-year, 0.769 for 3-year, and 0.799 for 5-year, respectively, in the development cohort, and was 0.731 for 1-year, 0.748 for 3-year, and 0.752 for 5-year, respectively, in the validation cohort. The calibration curves for 1-year, 3-year, and 5-year CSS showed great concordance. Significant differences were observed between high, medium, and low risk groups (P < 0.001 ). Conclusions . We haveAbstract : Purpose . To establish a prognostic model that estimates cancer-specific survival (CSS) probability for muscle-invasive bladder cancer patients undergoing partial cystectomy. Patients and Methods . 866 patients from the Surveillance, Epidemiology, and End Results (SEER) database (2004–2015) were enrolled in our study. These patients were randomly divided into the development cohort ( n = 608) and validation cohort ( n = 258) at a ratio of 7 : 3. A Cox regression was performed to select the predictors associated with CSS. The Kaplan–Meier method was used to analyze the survival outcome between different risk groups. The calibration curves, receiver operating characteristic (ROC) curves, and the concordance index (C-index) were utilized to evaluate the performance of the model. Results . The nomogram incorporated age, histology, T stage, N stage, M stage, regional nodes examined, and tumour size. The C-index of the model was 0.733 (0.696–0.77) in the development cohort, while this value was 0.707 (0.705–0.709) in the validation cohort. The AUC of the nomogram was 0.802 for 1-year, 0.769 for 3-year, and 0.799 for 5-year, respectively, in the development cohort, and was 0.731 for 1-year, 0.748 for 3-year, and 0.752 for 5-year, respectively, in the validation cohort. The calibration curves for 1-year, 3-year, and 5-year CSS showed great concordance. Significant differences were observed between high, medium, and low risk groups (P < 0.001 ). Conclusions . We have constructed a highly discriminative and precise nomogram and a corresponding risk classification system to predict the cancer-specific survival for muscle-invasive bladder cancer patients undergoing partial cystectomy. The model can assist in the decision on choice of treatment, patient counselling, and follow-up scheduling. … (more)
- Is Part Of:
- Journal of oncology. Volume 2022(2022)
- Journal:
- Journal of oncology
- Issue:
- Volume 2022(2022)
- Issue Display:
- Volume 2022, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 2022
- Issue:
- 2022
- Issue Sort Value:
- 2022-2022-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-03-01
- Subjects:
- Oncology -- Research -- Periodicals
Tumors -- Periodicals
Neoplasms
Oncology -- Research
Tumors
Periodicals
Periodicals
616.994 - Journal URLs:
- https://www.hindawi.com/journals/jo/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=859&action=archive ↗ - DOI:
- 10.1155/2022/2665711 ↗
- Languages:
- English
- ISSNs:
- 1687-8450
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 21870.xml